Greenburgh Approves Regeneron Expansion Plan
Real Estate In-Depth | November 2017
GREENBURGH—The Town Board of Greenburgh approved earlier this month the site plan application of Regeneron Pharmaceuticals of Tarrytown for a new research and development campus on a portion of a 100-acre parcel in the northern section of the town.
Town Supervisor Paul Feiner announced that the Town Board granted site plan approval and a negative declaration on any adverse environmental impacts on the project that could eventually involve the development of up to nine buildings totaling more than 1,016,190 square feet of research and development and related spaces at the property. A Regeneron spokesman stated in connection with the site plan approval, “Regeneron continues to expand as we advance our mission of bringing important new medicines to people with serious diseases. This recent site plan approval will provide us the flexibility to potentially expand our R&D campus in the future as needed. We appreciate the continued support of our communities, county and New York State in helping us plan for our ongoing growth.”
Feiner in an e-mail stated, “The potential expansion will further cement the growth of this bio-tech cluster in the Town of Greenburgh, Westchester County and New York State, and builds upon the vision laid out by the Town Board in the Town of Greenburgh’s Comprehensive Plan. The architectural renderings submitted in support of the plan are remarkable. The approved plan was designed to have a village-like feel and incorporates structured parking, plaza space, outdoor collaboration space, and integrated open space, in environmentally sustainable (projected LEED Silver, minimum) buildings.”